The Wisconsin Department of Health Services (DHS) has confirmed two tragic pediatric deaths resulting from respiratory syncytial virus (RSV), a respiratory illness. A second death was reported in the northeastern region of the state, and numerous young children are currently hospitalized due to RSV, as per the DHS Communications Specialist Elizabeth Goodsitt.

In addition to RSV, the state is grappling with significant levels of influenza and COVID-19. RSV activity is notably increasing among children under the age of 5, while influenza cases are surging among school-aged children. These respiratory illnesses have been on the rise statewide, creating a pressing need for preventive measures to protect lives.

Tom Haupt, the DHS Respiratory Diseases Epidemiologist, emphasized the importance of vaccination in combating the spread of respiratory illnesses. He urged all eligible residents in Wisconsin to receive their vaccinations promptly, stating that these vaccines are safe, effective, and instrumental in preventing severe illnesses, hospitalizations, and fatalities during the respiratory illness season.

DHS is calling on Wisconsinites, particularly children, older adults, and pregnant individuals, to prioritize getting vaccinated against respiratory illnesses and practicing good prevention techniques like frequent handwashing. The agency underlined the efficacy of respiratory illness vaccines in reducing symptoms and preventing infections of COVID-19, flu, and RSV.

To provide specific guidance, DHS advised individuals aged 60 and older, pregnant women, and caregivers of children under 19 months to consult their healthcare providers for recommendations on RSV vaccination or preventive treatment. For the protection of children, two options are available: an RSV vaccine (Abrysvo) for pregnant individuals between 32 and 36 weeks of pregnancy during RSV season, which provides antibodies to newborns until they reach 6 months old, and a monoclonal antibody shot (nirsevimab) for children under 8 months old born during or entering the RSV season. Nirsevimab is also suitable for children between 8 and 19 months old who are at higher risk for severe RSV disease in their second RSV season.

Wisconsin residents seeking flu and COVID-19 vaccination locations can visit vaccines.gov or call 211 or 877-947-2211 for further assistance. For the latest information on the current respiratory virus season, Wisconsinites can consult the DHS Weekly Respiratory Report.

The growing presence of RSV, influenza, and COVID-19 underscores the importance of proactive measures to safeguard public health. Vaccination and adherence to prevention practices are crucial steps in reducing the spread of these respiratory illnesses and protecting the well-being of Wisconsinites.